Last updated: 11/07/2018 11:46:37
Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)
Trial description: The objective of this study is to examine the effects of ropinirole CR on individual PD motor dysfunctions by calculating change in subtotal scores among components that correspond to each typical motor dysfunction - tremor, rigidity, bradykinesia, and postural instability/gait difficulty (PIGD).
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
UPDRS Part II and III score
Timeframe: N/A
Secondary outcomes:
UPDRS Part II and III subtotal score
Timeframe: N/A
Interventions:
Not applicable
Enrollment:
0
Primary completion date:
Not applicable
Observational study model:
Other
Time perspective:
Other
Clinical publications:
N Hattori, H Ozeki, H Hashimoto, K Hasegawa. Effect of ropinirole controlled-release on individual motor dysfunctions in early Parkinson’s disease. J Clin Therapeut Med.2013;29(11):961-966
Medical condition
Parkinson Disease
Product
ropinirole
Collaborators
Not applicable
Study date(s)
July 2013 to August 2013
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
Not applicable
Accepts healthy volunteers
none
- Same as ROP106064
- Same as ROP106064
Inclusion and exclusion criteria
Inclusion criteria:
- Same as ROP106064
Exclusion criteria:
- Same as ROP106064
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
Protocol
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2013-10-08
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website